Richard Russo

A 30+ year MedTech veteran, Richard has been a successful leader in both large corporate and start-up companies. Veteran of 2 successful start-ups, one in US (orthopaedics – M&A exit) and the other in France (human and xenogeneic tissue grafts – M&A exit). Richard is a hands-on leader with particular strengths in product development, clinical trials, regulatory affairs and international. Prior to Endomedix, was président-directeur général of corporate-backed start-up, OST-Développement SA in France. He established OST marketing and regulatory approvals throughout Europe, Middle East, Latin America and Asia, and a subsidiary in Bulgaria. At Endomedix, Richard changed the business model, revised product-market strategy, and led development of PLEXimine platform. He obtained 9 issued patents, and is the lead private investor with $1.1 M cash investment + deferred compensation. Richard earned a BA cum laude at Boston College and a MBA at Columbia Business School.